Carl Zeiss Meditec Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Markus Weber

Chief executive officer

€1.1m

Total compensation

CEO salary percentage40.5%
CEO tenure2.3yrs
CEO ownershipn/a
Management average tenure4yrs
Board average tenure2.9yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Markus Weber's remuneration changed compared to Carl Zeiss Meditec's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

€277m

Sep 30 2023€1m€426k

€290m

Jun 30 2023n/an/a

€308m

Mar 31 2023n/an/a

€278m

Dec 31 2022n/an/a

€307m

Sep 30 2022€1m€298k

€294m

Compensation vs Market: Markus's total compensation ($USD1.13M) is below average for companies of similar size in the UK market ($USD5.62M).

Compensation vs Earnings: Markus's compensation has been consistent with company performance over the past year.


CEO

Markus Weber

2.3yrs

Tenure

€1,050,400

Compensation

Dr. Markus Weber is CEO & Chairman of Management Board of Carl Zeiss Meditec AG from January 01, 2022 and served as its President since January 01, 2022 until December 2022. He joined ZEISS Semiconductor M...


Leadership Team

NamePositionTenureCompensationOwnership
Markus Weber
CEO & Chairman of Management Board2.3yrs€1.05mno data
Justus Wehmer
CFO & Member of the Management Board5.5yrs€799.30kno data
Christian Munster
Head of Global Regulatory & Clinical Affairs1.3yrsno datano data
Stefanie Spanagel
Chief Operating Officerno datano datano data
Sebastian Frericks
Director of Investor Relationsno datano datano data
Eva-Maria Heine
Chief Human Resources Officerno datano datano data
Steven Schallhorn
Chief Medical Officer for Global Ophthalmic Devices7.5yrsno datano data
Andrew Chang
Head of Sales for Ophthalmic Devices & President of Carl Zeiss Meditec4.1yrsno datano data
Euan Thomson
President of Ophthalmic Devices and Head of the Ophthalmic Devices Strategic & Digital Business Unit3.9yrsno datano data
Magnus Reibenspiess
Head of the Microsurgery Strategic Business Unit - ZEISS Medical Technologyno datano datano data

4.0yrs

Average Tenure

58yo

Average Age

Experienced Management: 0DHC's management team is considered experienced (4 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Christian Munster
Head of Global Regulatory & Clinical Affairs1.1yrsno datano data
Karl Lamprecht
Chairman of the Supervisory Board3.8yrsno datano data
Michael Kaschke
Honorary Chairman of the Supervisory Board2.9yrs€43.10kno data
Isabel De Paoli
Member of the Supervisory Board3.8yrs€36.00kno data
Peter Kameritsch
Member of the Supervisory Board2.9yrs€55.00kno data
Heike Madan
Employee Representative Member of the Supervisory Board1.1yrsno datano data
Tania von der Goltz
Member of the Supervisory Board6yrs€52.00kno data
Rene Denner
Employee Representative Deputy Chairman of Supervisory Board4.5yrs€40.50kno data
Jeffrey Marx
Employee Representative Member of Supervisory Board4.1yrs€36.00kno data
Torsten Reitze
Member of Supervisory Board2.9yrsno datano data
Brigitte Koblizek
Employee Representative Member of the Supervisory Board2.1yrs€19.20kno data
Falk Bindheim
Employee Representative Member of the Supervisory Board1.1yrsno datano data

2.9yrs

Average Tenure

52yo

Average Age

Experienced Board: 0DHC's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.